Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow MOH
Molina Healthcare, Inc (MOH) P/E ratio
Molina Healthcare, Inc has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 68.0× (June 2026) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 20.3× | 42.31% |
| FY2024 | 14.2× | (27.99%) |
| FY2023 | 19.8× | (15.95%) |
| FY2022 | 23.5× | (16.76%) |
| FY2021 | 28.3× | 49.29% |
| FY2020 | 18.9× | 60.09% |
| FY2019 | 11.8× | 7.59% |
| FY2018 | 11.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 58.1× | 147.38% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 39.4× | 94.53% |
| Dec 2025 | 20.3× | 71.10% |
| Sep 2025 | 11.8× | (19.30%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CNC Centene Corporation compare | n/m |
| MOH Molina Healthcare, Inc | n/m |
| CLOV Clover Health Investments, Corp. compare | n/m |
| CI Cigna Group compare | 11.7× |
| ELV Elevance Health, Inc. compare | 18.8× |
| OSCR Oscar Health, Inc. compare | 19.8× |
| PGNY Progyny, Inc. compare | 28.2× |
| HUM Humana Inc. compare | 39.5× |
| ALHC Alignment Healthcare, Inc. compare | 39.5× |
| Healthcare Plans industry median | 23.6× |
| Healthcare sector median | 22.8× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)